Breast Cancer
Low levels of PPARgamma and PGC-I are associated with poor clinical outcomes
Published in Women's Health Weekly, October 16th, 2003
"Peroxisome-proliferator activated receptor-gamma (PPARgamma) belongs to a family of nuclear receptors and acts as receptor for peroxisome-proliferators, steroids, retinoic acids, and polyunsaturated fatty acids," investigators in Wales report.
"Our study examined the transcript levels of peroxisome-proliferator activated receptorgamma (PPARgamma) and its co-activator (PGC-I) in a cohort of patients with breast cancer. An invasive breast cancer cell, MDA MB 231 exhibited lower level of expression of PPAR-gamma compared to noninvasive MCF-7," wrote W.G. Jiang and colleagues,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Contrast mammography reveals hard-to-find cancers - Gynecology
Postmenopausal women have rapid bone loss after withdrawal from long-term HRT - Adolescent Health
Peer reputation, self-concept, and coping status mark smoking in teenage girls - Cervical Cancer
A single vaccine could benefit most women - Eating Disorders
Lack of maternal physical or psychic reference may underlie anorexia nervosa - Gastroenterology
A gynecological approach to appendectomy can yield good results - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
